Running Point Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,625
Closed -$269K – 151
2023
Q2
$269K Sell
1,625
-8
-0.5% -$1.29K 0.15% 81
2023
Q1
$253K Sell
1,633
-56
-3% -$9.04K 0.15% 82
2022
Q4
$298K Buy
1,689
+107
+7% +$18.5K 0.18% 70
2022
Q3
$258K Buy
1,582
+164
+12% +$27.8K 0.17% 71
2022
Q2
$252K Sell
1,418
-141
-9% -$25.1K 0.16% 78
2022
Q1
$276K Buy
1,559
+206
+15% +$35.1K 0.16% 76
2021
Q4
$231K Sell
1,353
-218
-14% -$35.7K 0.14% 72
2021
Q3
$254K Buy
1,571
+148
+10% +$25.3K 0.11% 91
2021
Q2
$234K Buy
+1,423
New +$236K 0.11% 86

Other funds holding JNJ

Running Point Capital Advisors's JNJ Position: Q3 2023 in Review

Running Point Capital Advisors sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 1,625 shares — an estimated $269K sold.

Running Point Capital Advisors first reported a position in JNJ in Q2 2021 and held it in 9 quarters. The position peaked at $298K in Q4 2022. 3,682 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Running Point Capital Advisors reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Running Point Capital Advisors sold 1,625 Johnson & Johnson shares in Q3 2023, an estimated $269K.
  • Running Point Capital Advisors first reported a position in Johnson & Johnson in Q2 2021 and held it in 9 quarters.
  • Running Point Capital Advisors's Johnson & Johnson position peaked at $298K in Q4 2022.
  • 3,682 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Running Point Capital Advisors's 13F filing for Q3 2023, filed 6 Nov 2023.